Status:
COMPLETED
Dexmedetomidine Infusion During Laparoscopic Adrenalectomy
Lead Sponsor:
Yonsei University
Conditions:
Pheochromocytoma
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
The investigators planned this study to investigate the effects of dexmedetomidine administration on intraoperative hemodynamic stability in patients with pheochromocytoma.
Eligibility Criteria
Inclusion
- ages of 20 and 70
- American Society of Anesthesiologists(ASA) physical status classification I to III,
- planned laparoscopic adrenalectomy for pheochromocytoma.
Exclusion
- emergency operation,
- re-operation,
- combined surgery with other departments,
- body mass index (BMI) \>32 kg/m2,
- history of arrhythmias (especially AV nodal block) and ventricular conduction abnormalities,
- uncontrolled hypertension (diastolic blood pressure \>110mmHg)
- bradycardia (heart rate \< 40 beats per minute),
- history of heart failure, hepatic and/or renal failure,
- history of cerebrovascular disease (cerebral hemorrhage, cerebral ischemia),
- history of beta-blocker therapy, 10) history of uncontrolled psychiatric disease.
Key Trial Info
Start Date :
December 3 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 26 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06037135
Start Date
December 3 2012
End Date
March 26 2021
Last Update
October 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Severance hospital
Seoul, South Korea